In lung cancer, PLK1 inhibits DC maturation and T-cell enrichment (98, 99).Moreover, PLK1 expression is positively correlated with myeloid-derived suppressor cells (MDSCs) and regulatory T cells. The gene discussed is PLK1; the disease is lung carcinoma.